Novavax (NVAX) Tops Q4 EPS by 60c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $12.56 --0%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
TMQ, OMH, AEHR, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
TMQ, OMH, AEHR, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of $0.11, $0.60 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $147 million versus the consensus estimate of $90.25 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Diodes (DIOD) at Buy
- Blaize Holdings reports ~$0.5M in preliminary Q3 2026 revenue
- PG&E Corporation (PCG) PT Lowered to $15.50 at Ladenburg Thalmann
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
